| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/1999 | CN1229077A Process for preparation of 3-amino-pyrrolidine derivatives |
| 09/22/1999 | CN1229076A Trimethlene imidic derivant and composition for promoting two-tailed bacterium division using the derivant as active principle and making method thereof |
| 09/22/1999 | CN1228994A Pharmaceutical composition of hedgehog proteins and use thereof |
| 09/22/1999 | CN1228990A Prescription of antasthmatic powder and preparation method thereof |
| 09/22/1999 | CN1228972A Medicine for treating burn |
| 09/22/1999 | CN1228969A A set of medicine for prevention and curing of cholesthiasis disease and plan for discriminating choleithiasis kind |
| 09/22/1999 | CN1228968A Production method for extracting flavonoid compound extract or powder from bamboo leaf |
| 09/22/1999 | CN1228967A Traditional Chinese medicine preparation for treating nasal meatus disease and cataract |
| 09/22/1999 | CN1228961A Application of alginic polysaccharide sulfate in preparation of medicine for treating renal failure |
| 09/22/1999 | CN1228960A Thrombus clearing soft capsule and preparation technology thereof |
| 09/22/1999 | CN1228958A Radix aconiti kunsezoffii nail element soft capsule and production method thereof |
| 09/22/1999 | CN1228933A Rice with weight-reducing function |
| 09/22/1999 | CN1045208C Isoamyl tadine compound, its preparation method and microbe for producing the compound |
| 09/22/1999 | CN1045207C Farnesyl: protein transfer-enzyme inhibitors as anticancer agents |
| 09/22/1999 | CN1045206C Method for preparing cyclic amide derivative |
| 09/22/1999 | CN1045204C 10,11-methanodibenzosuberane derivatives, preparation method and composition |
| 09/22/1999 | CN1045168C Shenshixiao capsule for eliminating kidney stone |
| 09/22/1999 | CN1045160C Hair growth modification |
| 09/21/1999 | US5955632 Heart failure and hypotensive agents |
| 09/21/1999 | US5955624 Angiogenic isolated alk-1-enyl glycerol derivative |
| 09/21/1999 | US5955617 Also for treatment of impaired glucose tolerance, obesity |
| 09/21/1999 | US5955611 Cyclization of diamidepyrazole to form pyrimidone of pyrazole |
| 09/21/1999 | US5955608 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 09/21/1999 | US5955607 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them |
| 09/21/1999 | US5955603 Porphyrins and porphyrin synthesis techniques |
| 09/21/1999 | US5955602 Natural soluble polysaccharide of lactose possibly substituted with galactose, glucose, n-acetylgalactosamine, n-acetylneuramic acid, fucose, or sulfation; for use in cosmetics and food |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955591 Phosphotriester oligonucleotides, amidites and method of preparation |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955580 Vaccines for nontypable haemophilus influenzae |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955508 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens |
| 09/21/1999 | US5955507 Therapeutic substituted guanidines |
| 09/21/1999 | US5955505 Treating nerve degenerative disorders |
| 09/21/1999 | US5955504 Administering enantiomerically stable antiinflammatory agents/non-steroids/ or a pharmaceutically acceptable salts to treat colon cancer |
| 09/21/1999 | US5955503 Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like |
| 09/21/1999 | US5955500 Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of R- and S-verapamil |
| 09/21/1999 | US5955499 Phenylalkylaminoalcohol carbamates and process for preparing the same |
| 09/21/1999 | US5955498 Agent for prophylaxis and therapy of diseases |
| 09/21/1999 | US5955497 Antitumor agents and cytotoxicity |
| 09/21/1999 | US5955496 Dihydroxy-oxy-eicosadienoates |
| 09/21/1999 | US5955495 Method of treating diseases of the CNS |
| 09/21/1999 | US5955493 Thiamorphinans with neuroprotective activity |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955490 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 09/21/1999 | US5955489 Taxane derivatives, the preparation thereof and formulations containing them |
| 09/21/1999 | US5955488 Freeze-dried compositions |
| 09/21/1999 | US5955487 Treating high blood pressure, cardiac insufficiency, glaucoma |
| 09/21/1999 | US5955485 2,3-dihydro-imidazo(2,1-b)benzothiazole derivatives |
| 09/21/1999 | US5955482 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments |
| 09/21/1999 | US5955479 Levobupivacaine for managing chronic pain |
| 09/21/1999 | US5955478 Methods for treating gastrointestinal motility dysfunction using optically pure (+) cisapride |
| 09/21/1999 | US5955477 Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride |
| 09/21/1999 | US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
| 09/21/1999 | US5955475 Salt formation to anhydrate; vacuum evaporation of solvent; water solubility |
| 09/21/1999 | US5955474 Antiedema agents or diuretic antagonist |
| 09/21/1999 | US5955472 Naphthylazo inhibition of amyloidosis |
| 09/21/1999 | US5955471 Useful in the treatment of central nervous system disorders, including depression |
| 09/21/1999 | US5955470 Derivatives of amide analogs of certain methano bridged quinolizines |
| 09/21/1999 | US5955469 17-allyl-1,14-dihydroxy-12-(2-(4-hydroxy-3-methoxycyclohexyl)-1 -methylvinyl)-23,25-dimethoxy-12,19,21,27-tetramethyl-11,28-d ioxa-4-azatricyclo(22.3.1.0)octacos-18-18-ene-2,3,10,16-tetrao ne; lecithin, soybean oil; oil in water; immunosuppressants |
| 09/21/1999 | US5955468 Benzo G!quinolines for use in prevention or delay of progressive atrophy of the optic nerve |
| 09/21/1999 | US5955467 Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP |
| 09/21/1999 | US5955466 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/21/1999 | US5955464 4-anilinoquinazoline derivatives bearing a heteroaryl substituted at the 6-position and possessing anti-cell-proliferation properties |
| 09/21/1999 | US5955463 Antitumor, antiinflammatory, and antiarthritic agents |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955461 Quinoxalinedione derivatives, their production and use in pharmaceutical agents |
| 09/21/1999 | US5955460 Oxazolidinone antibacterial agent with tricyclic substituents |
| 09/21/1999 | US5955459 Fatty acid-antipsychotic compositions and uses thereof |
| 09/21/1999 | US5955458 Penicillin glycolate |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955456 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 09/21/1999 | US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/21/1999 | US5955454 Nasal pharmaceutical composition containing a progestogen |
| 09/21/1999 | US5955453 Membrane-permeant phosphoinositides |
| 09/21/1999 | US5955452 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 09/21/1999 | US5955451 Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
| 09/21/1999 | US5955448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/21/1999 | US5955447 Administering as anticoagulant; treating cardiovascular disorders |
| 09/21/1999 | US5955446 Viricides for herpes infections |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955442 Methods for treating respiratory disease |
| 09/21/1999 | US5955440 Macrolide LHRH antagonists |
| 09/21/1999 | US5955439 Inhalant includes antiasthmatic agent and fluorocarbon propellant; low ozone depletion potential |
| 09/21/1999 | US5955424 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955285 Method of identifying individuals at risk of suffering from cerebral amyloidosis |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955106 Hydrocolloid-forming agent as a retardant |
| 09/21/1999 | US5955105 Stabilized thyroid hormone preparations and methods of making same |
| 09/21/1999 | US5955104 Multiple unit oral pharmaceutical formulations |
| 09/21/1999 | US5955103 Dosage form comprising antiepileptic drug |
| 09/21/1999 | US5955100 Prodrugs their preparation and use as pharmaceuticals |
| 09/21/1999 | US5955098 C 3-8 linear or branched hydrocarbon propellant |
| 09/21/1999 | US5955089 Streptococcus for vaccines |